Rubicon Days Sales Outstanding vs Price To Sales Ratio Analysis

ROMJ Stock

CAD 0.33 0.01 3.13%

Rubicon Organics financial indicator trend analysis is much more than just breaking down Rubicon Organics prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Rubicon Organics is a good investment. Please check the relationship between Rubicon Organics Days Sales Outstanding and its Price To Sales Ratio accounts. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Rubicon Organics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in inflation.

Days Sales Outstanding vs Price To Sales Ratio

Days Sales Outstanding vs Price To Sales Ratio Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Rubicon Organics Days Sales Outstanding account and Price To Sales Ratio. At this time, the significance of the direction appears to have pay attention.

The correlation between Rubicon Organics' Days Sales Outstanding and Price To Sales Ratio is -0.75. Overlapping area represents the amount of variation of Days Sales Outstanding that can explain the historical movement of Price To Sales Ratio in the same time period over historical financial statements of Rubicon Organics, assuming nothing else is changed. The correlation between historical values of Rubicon Organics' Days Sales Outstanding and Price To Sales Ratio is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Days Sales Outstanding of Rubicon Organics are associated (or correlated) with its Price To Sales Ratio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Price To Sales Ratio has no effect on the direction of Days Sales Outstanding i.e., Rubicon Organics' Days Sales Outstanding and Price To Sales Ratio go up and down completely randomly.

Correlation Coefficient

-0.75

Relationship Direction	Negative
Relationship Strength	Weak

View All Relationships

Days Sales Outstanding

Price To Sales Ratio

Price to Sales Ratio is figured by comparing Rubicon Organics stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Rubicon Organics sales, a figure that is much harder to manipulate than other Rubicon Organics multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.

Most indicators from Rubicon Organics' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Rubicon Organics current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Rubicon Organics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in inflation.

At this time, Rubicon Organics' Enterprise Value Over EBITDA is fairly stable compared to the past year. Enterprise Value Multiple is likely to climb to 18.22 in 2024, whereas Discontinued Operations is likely to drop (765.1 K) in 2024.

	2021	2022	2023	2024 (projected)
Reconciled Depreciation	2.4M	3.1M	3.1M	1.9M
Total Operating Expenses	36.0M	38.1M	45.8M	27.0M

Reconciled Depreciation Total Operating Expenses

Rubicon Organics fundamental ratios Correlations

	Total Assets	Total Current Liabilities	Total Stockholder Equity	Net Tangible Assets	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Current Liabilities Total	Capital Lease Obligations	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Short Long Term Debt	Total Current Assets	Common Stock	Other Current Liab	Net Debt	Other Assets	Long Term Debt	Net Receivables	Common Stock Shares Outstanding	Net Invested Capital	Net Working Capital	Intangible Assets
Total Assets		0.79	0.97	0.97	-0.97	0.57	0.76	0.94	0.82	0.23	0.9	0.17	0.95	0.94	0.41	0.98	0.99	0.18	0.42	0.92	0.97	0.86	0.93	0.98	0.83	0.67
Total Current Liabilities	0.79		0.64	0.66	-0.78	0.67	0.66	0.72	0.48	0.52	0.69	0.37	0.74	0.92	0.86	0.81	0.75	0.37	0.53	0.8	0.82	0.53	0.61	0.73	0.45	0.3
Total Stockholder Equity	0.97	0.64		1.0	-0.92	0.43	0.78	0.93	0.81	0.17	0.9	-0.04	0.92	0.83	0.23	0.93	0.97	-0.02	0.23	0.86	0.9	0.9	0.97	0.98	0.87	0.74
Net Tangible Assets	0.97	0.66	1.0		-0.93	0.5	0.75	0.95	0.8	0.16	0.87	0.01	0.91	0.84	0.26	0.93	0.98	0.02	0.27	0.87	0.9	0.87	0.95	0.97	0.83	0.71
Retained Earnings	-0.97	-0.78	-0.92	-0.93		-0.6	-0.69	-0.94	-0.86	-0.19	-0.92	-0.19	-0.99	-0.92	-0.38	-0.93	-0.96	-0.19	-0.49	-0.93	-0.92	-0.88	-0.87	-0.94	-0.85	-0.59
Accounts Payable	0.57	0.67	0.43	0.5	-0.6		0.14	0.7	0.46	0.12	0.28	0.6	0.52	0.69	0.5	0.49	0.6	0.53	0.71	0.7	0.49	0.19	0.26	0.42	0.18	-0.02
Cash	0.76	0.66	0.78	0.75	-0.69	0.14		0.58	0.43	0.62	0.8	-0.25	0.69	0.67	0.49	0.83	0.72	-0.18	-0.08	0.53	0.78	0.73	0.84	0.82	0.69	0.44
Non Current Assets Total	0.94	0.72	0.93	0.95	-0.94	0.7	0.58		0.82	0.08	0.81	0.16	0.92	0.87	0.32	0.87	0.97	0.13	0.44	0.94	0.84	0.79	0.83	0.89	0.74	0.62
Non Current Liabilities Total	0.82	0.48	0.81	0.8	-0.86	0.46	0.43	0.82		-0.25	0.83	0.29	0.9	0.75	-0.03	0.78	0.81	0.33	0.57	0.78	0.8	0.85	0.79	0.81	0.91	0.68
Capital Lease Obligations	0.23	0.52	0.17	0.16	-0.19	0.12	0.62	0.08	-0.25		0.19	-0.14	0.14	0.28	0.74	0.3	0.2	-0.15	-0.14	0.2	0.27	0.06	0.19	0.25	-0.03	-0.27
Inventory	0.9	0.69	0.9	0.87	-0.92	0.28	0.8	0.81	0.83	0.19		-0.02	0.96	0.82	0.31	0.91	0.86	0.03	0.28	0.78	0.9	0.97	0.94	0.94	0.94	0.73
Other Current Assets	0.17	0.37	-0.04	0.01	-0.19	0.6	-0.25	0.16	0.29	-0.14	-0.02		0.15	0.42	0.29	0.19	0.15	0.99	0.93	0.33	0.28	-0.15	-0.09	0.05	-0.04	-0.12
Other Stockholder Equity	0.95	0.74	0.92	0.91	-0.99	0.52	0.69	0.92	0.9	0.14	0.96	0.15		0.9	0.32	0.92	0.94	0.17	0.46	0.91	0.92	0.93	0.9	0.95	0.9	0.66
Total Liab	0.94	0.92	0.83	0.84	-0.92	0.69	0.67	0.87	0.75	0.28	0.82	0.42	0.9		0.61	0.94	0.92	0.44	0.62	0.91	0.96	0.71	0.8	0.89	0.69	0.52
Short Long Term Debt	0.41	0.86	0.23	0.26	-0.38	0.5	0.49	0.32	-0.03	0.74	0.31	0.29	0.32	0.61		0.46	0.37	0.27	0.3	0.44	0.47	0.1	0.22	0.34	-0.01	-0.09
Total Current Assets	0.98	0.81	0.93	0.93	-0.93	0.49	0.83	0.87	0.78	0.3	0.91	0.19	0.92	0.94	0.46		0.96	0.23	0.4	0.86	0.99	0.84	0.94	0.98	0.83	0.65
Common Stock	0.99	0.75	0.97	0.98	-0.96	0.6	0.72	0.97	0.81	0.2	0.86	0.15	0.94	0.92	0.37	0.96		0.16	0.41	0.93	0.93	0.83	0.91	0.97	0.8	0.66
Other Current Liab	0.18	0.37	-0.02	0.02	-0.19	0.53	-0.18	0.13	0.33	-0.15	0.03	0.99	0.17	0.44	0.27	0.23	0.16		0.9	0.3	0.33	-0.1	-0.03	0.09	0.03	-0.06
Net Debt	0.42	0.53	0.23	0.27	-0.49	0.71	-0.08	0.44	0.57	-0.14	0.28	0.93	0.46	0.62	0.3	0.4	0.41	0.9		0.6	0.49	0.17	0.17	0.32	0.26	0.09
Other Assets	0.92	0.8	0.86	0.87	-0.93	0.7	0.53	0.94	0.78	0.2	0.78	0.33	0.91	0.91	0.44	0.86	0.93	0.3	0.6		0.86	0.73	0.78	0.87	0.68	0.56
Long Term Debt	0.97	0.82	0.9	0.9	-0.92	0.49	0.78	0.84	0.8	0.27	0.9	0.28	0.92	0.96	0.47	0.99	0.93	0.33	0.49	0.86		0.82	0.92	0.96	0.82	0.66
Net Receivables	0.86	0.53	0.9	0.87	-0.88	0.19	0.73	0.79	0.85	0.06	0.97	-0.15	0.93	0.71	0.1	0.84	0.83	-0.1	0.17	0.73	0.82		0.94	0.91	0.97	0.77
Common Stock Shares Outstanding	0.93	0.61	0.97	0.95	-0.87	0.26	0.84	0.83	0.79	0.19	0.94	-0.09	0.9	0.8	0.22	0.94	0.91	-0.03	0.17	0.78	0.92	0.94		0.98	0.91	0.8
Net Invested Capital	0.98	0.73	0.98	0.97	-0.94	0.42	0.82	0.89	0.81	0.25	0.94	0.05	0.95	0.89	0.34	0.98	0.97	0.09	0.32	0.87	0.96	0.91	0.98		0.89	0.73
Net Working Capital	0.83	0.45	0.87	0.83	-0.85	0.18	0.69	0.74	0.91	-0.03	0.94	-0.04	0.9	0.69	-0.01	0.83	0.8	0.03	0.26	0.68	0.82	0.97	0.91	0.89		0.74
Intangible Assets	0.67	0.3	0.74	0.71	-0.59	-0.02	0.44	0.62	0.68	-0.27	0.73	-0.12	0.66	0.52	-0.09	0.65	0.66	-0.06	0.09	0.56	0.66	0.77	0.8	0.73	0.74

Click cells to compare fundamentals

Rubicon Organics Account Relationship Matchups

Rubicon Organics fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	39.8M	51.1M	54.8M	56.1M	64.5M	41.7M
Total Current Liabilities	12.9M	22.0M	6.9M	8.4M	9.6M	8.8M
Total Stockholder Equity	18.5M	28.8M	38.9M	38.3M	44.1M	27.6M
Net Tangible Assets	20.2M	16.6M	27.0M	37.0M	42.6M	22.5M
Retained Earnings	(56.3M)	(71.3M)	(85.8M)	(89.7M)	(80.7M)	(84.8M)
Accounts Payable	2.6M	1.7M	1.6M	681.2K	783.4K	744.3K
Cash	2.1M	12.1M	11.6M	8.3M	9.5M	6.4M
Non Current Assets Total	21.4M	24.9M	27.7M	28.4M	32.7M	24.5M
Non Current Liabilities Total	8.4M	221.1K	9.0M	9.4M	10.8M	11.4M
Capital Lease Obligations	65.5K	344.1K	211.1K	59.0K	67.8K	64.5K
Inventory	4.1M	10.1M	10.6M	12.7M	14.6M	15.3M
Other Current Assets	992.0K	11.5M	445.9K	152.1K	174.9K	166.2K
Other Stockholder Equity	7.4M	11.3M	13.8M	17.5M	20.2M	21.2M
Total Liab	21.3M	22.2M	15.9M	17.8M	20.4M	14.1M
Short Long Term Debt	4.9M	13.6M	659.3K	758.5K	872.2K	828.6K
Total Current Assets	18.4M	26.2M	27.2M	27.7M	31.8M	16.7M
Common Stock	56.7M	63.6M	86.3M	107.2M	123.3M	63.0M
Net Debt	3.0M	11.1M	1.5M	1.9M	2.1M	3.9M
Long Term Debt	2.8M	8.4M	8.9M	9.4M	10.8M	7.1M
Net Receivables	204.9K	2.2M	4.1M	4.8M	5.5M	5.8M
Common Stock Shares Outstanding	40.0M	49.4M	56.0M	56.1M	64.5M	50.4M
Net Invested Capital	31.7M	42.5M	48.5M	48.5M	55.8M	39.7M
Net Working Capital	5.5M	4.2M	20.2M	19.3M	22.2M	23.3M
Property Plant Equipment	24.0M	19.5M	22.5M	25.3M	29.1M	23.7M
Capital Stock	63.6M	86.3M	107.2M	107.6M	123.8M	92.7M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Rubicon Stock Analysis

When running Rubicon Organics' price analysis, check to measure Rubicon Organics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Rubicon Organics is operating at the current time. Most of Rubicon Organics' value examination focuses on studying past and present price action to predict the probability of Rubicon Organics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Rubicon Organics' price. Additionally, you may evaluate how the addition of Rubicon Organics to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC